Atracurium Besylate 100 mg | ≥95% LKT Laboratories, Inc. Non-depolarizing NMJ blocker; AChR antagonist. More Information Supplier Page × Atracurium Besylate
Atracurium Besylate 50 mg | ≥95% LKT Laboratories, Inc. Non-depolarizing NMJ blocker; AChR antagonist. More Information Supplier Page × Atracurium Besylate
Atosiban Acetate 2.5 mg | ≥95% LKT Laboratories, Inc. Peptide, alters uterine contractility; V1/2 and OXTR antagonist. More Information Supplier Page × Atosiban Acetate
Atosiban Acetate 1 mg | ≥95% LKT Laboratories, Inc. Peptide, alters uterine contractility; V1/2 and OXTR antagonist. More Information Supplier Page × Atosiban Acetate
Atriopeptin I 1 mg | ≥95% LKT Laboratories, Inc. ANP analog, cardiomodulatory peptide; weak NPR-A agonist. More Information Supplier Page × Atriopeptin I
Atriopeptin I 2.5 mg | ≥95% LKT Laboratories, Inc. ANP analog, cardiomodulatory peptide; weak NPR-A agonist. More Information Supplier Page × Atriopeptin I
2B-(S) 5 mg | ≥95% LKT Laboratories, Inc. Peptide-biotin conjugate. More Information Supplier Page × 2B-(S)
2B-(S) 2 mg | ≥95% LKT Laboratories, Inc. Peptide-biotin conjugate. More Information Supplier Page × 2B-(S)
2B-(S) 1 mg | ≥95% LKT Laboratories, Inc. Peptide-biotin conjugate. More Information Supplier Page × 2B-(S)
Autocamtide 2 2.5 mg | ≥95% LKT Laboratories, Inc. Peptide, CamKII substrate. More Information Supplier Page × Autocamtide 2
